1st BIOPHARMACEUTICAL CLINICAL DEVELOPMENT SUMMIT
Time：2017-06-11 -06-12location：zhejiang ningboshi
In recent years, biological drugs IND applications are increasing in China. Domestic leading biopharmaceutical companies in clinical applications have been approved by the CFDA. Some experts predict that by 2020, there will be a new biopharmaceutical listed.
Clinical communication and interaction have become increasingly frequent. In order to provide a communication platform for government, enterprise, doctor and etc, Enmore Healthcare is going to hold the 1st BIOPHARMACEUTICAL CLINICAL DEVELOPMENT SUMMIT!
Why attend?
l Access to the latest information on the clinical development of biopharmaceuticals
l Discussion on future development of biological drugs
l Promote the healthy development of biopharmaceutical industry
Event Highlights
Focus on the hotspot of biopharmaceutical clinical
Pay attention to the compliance of clinical progress
Promote exchanges between enterprises, governments and hospitals
